AndrewAronsohnAndrew Aronsohn41.78927490000000-87.601250000000001306Aronsohn, AndrewAssociate Professorprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMichaelCharltonMichael Charlton0.000000000000000.000000000000003423Charlton, MichaelProfessorAuthorship 101712227904243Gondal B, Aronsohn ASeminars in interventional radiologyA Systematic Approach to Patients with Jaundice. Semin Intervent Radiol. 2016 Dec; 33(4):253-258.Semin Intervent Radiol2016-12-01T00:00:002016A Systematic Approach to Patients with Jaundice.Authorship 103218128252562Aronsohn ATransplantationTiming Is Everything: Managing Hepatitis C Virus in Liver Transplant Candidates. Transplantation. 2017 05; 101(5):898-899.Transplantation2017-05-01T00:00:002017Timing Is Everything: Managing Hepatitis C Virus in Liver Transplant Candidates.D000998Chemicals & Drugs1355080.732386Antiviral AgentsVijayaRaoVijaya Rao41.7886000000000087.598699999999993538Rao, VijayaAssistant ProfessorMedicine-GastroenterologyMedicine-Infectious DiseasesMicrobiology29790191Couri T, Gupta T, Weyer G, Aronsohn AHepatology (Baltimore, Md.)Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents. Hepatology. 2018 11; 68(5):2004-2007.Hepatology2018-10-13T00:00:002018Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents.Authorship 1089744Authorship 118595229905289Coronel E, Aronsohn A, Gelrud A, Siddiqui UDVideoGIE : an official video journal of the American Society for Gastrointestinal EndoscopyThe incredible shrinking waistline: lumen-apposing metal stent treatment of massive ascites. VideoGIE. 2017 Aug; 2(8):197-198.VideoGIE2017-05-26T00:00:002017The incredible shrinking waistline: lumen-apposing metal stent treatment of massive ascites.D005762Occupations471340.834257GastroenterologyD006526Disorders712080.813881Hepatitis CAuthorship 128978330988937Cotter TG, Stier MW, Aronsohn AClinical liver diseasePRO: Needle Exchange Programs Should Be Instituted to Reduce Hepatitis C Virus Transmission. Clin Liver Dis (Hoboken). 2018 Dec; 12(6):170-172.Clin Liver Dis (Hoboken)2019-01-02T00:00:002019PRO: Needle Exchange Programs Should Be Instituted to Reduce Hepatitis C Virus Transmission.31186840Aronsohn A, Jensen DClinical liver diseaseThe long-term horizon: Patients who will remain untreated in the era of triple therapy. Clin Liver Dis (Hoboken). 2012 Feb; 1(1):20-23.Clin Liver Dis (Hoboken)2012-03-06T00:00:002012The long-term horizon: Patients who will remain untreated in the era of triple therapy.Authorship 1300041Authorship 134441531737694Mikolajczyk AE, Fung J, Paul S, Chang B, Aronsohn AIACG case reports journalHerniated Umbilical Varix in a Patient With Cirrhosis. ACG Case Rep J. 2019 Aug; 6(8):e00151.ACG Case Rep J2019-08-14T00:00:002019Herniated Umbilical Varix in a Patient With Cirrhosis.Authorship 391125Authorship 13468531816111Ghany MG, Morgan TR, AASLD-IDSA Hepatitis C Guidance PanelHepatology (Baltimore, Md.)Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 02; 71(2):686-721.Hepatology2020-02-01T00:00:002020Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.Authorship 447521Authorship 381301Authorship 406671Authorship 137328232371167Odenwald MA, Aronsohn A, Peeraphatidit TBClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationA Rare Case of an Aggressive Liver Tumor. Clin Gastroenterol Hepatol. 2021 07; 19(7):e72.Clin Gastroenterol Hepatol2020-05-01T00:00:002020A Rare Case of an Aggressive Liver Tumor.Authorship 432071Authorship 137752232445954Couri T, Aronsohn AClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationYou Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2021 10; 19(10):2015-2019.Clin Gastroenterol Hepatol2020-05-20T00:00:002020You Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology.Authorship 490181Authorship 491512Authorship 139112232639400Cotter TG, Aronsohn A, Reddy KG, Charlton MTransplantationLiver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation. Transplantation. 2021 06 01; 105(6):1285-1290.Transplantation2021-06-01T00:00:002021Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.Authorship 139766432745283Kastin D, Siegel M, Anderson R, Aronsohn AHepatology (Baltimore, Md.)IgG 4 Autoimmune Hepatitis Presenting as Idiopathic Hypereosinophilia Syndrome. Hepatology. 2021 04; 73(4):1615-1617.Hepatology2021-04-01T00:00:002021IgG 4 Autoimmune Hepatitis Presenting as Idiopathic Hypereosinophilia Syndrome.Authorship 140230532843977Rao VL, Gupta N, Swei E, Wagner T, Aronsohn A, Reddy KG, Sengupta NGastroenterology reportPredictors of mortality and endoscopic intervention in patients with upper gastrointestinal bleeding in the intensive care unit. Gastroenterol Rep (Oxf). 2020 Aug; 8(4):299-305.Gastroenterol Rep (Oxf)2020-04-01T00:00:002020Predictors of mortality and endoscopic intervention in patients with upper gastrointestinal bleeding in the intensive care unit.Authorship 143538233497657Rao VL, Aronsohn A, Rubin DT, Siegler MGastroenterologyHow to Integrate a Medical Ethics Curriculum into Gastroenterology Fellowships. Gastroenterology. 2021 03; 160(4):1003-1006.Gastroenterology2021-01-23T00:00:002021How to Integrate a Medical Ethics Curriculum into Gastroenterology Fellowships.19448563Aronsohn A, Reau NJournal of clinical gastroenterologyLong-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol. 2009 Aug; 43(7):661-71.J Clin Gastroenterol2009-08-01T00:00:002009Long-term outcomes after treatment with interferon and ribavirin in HCV patients.20199503Aronsohn A, Thistlethwaite JR, Segev DL, Ross LFAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsHow different conceptions of risk are used in the organ market debate. Am J Transplant. 2010 Apr; 10(4):931-937.Am J Transplant2010-02-25T00:00:002010How different conceptions of risk are used in the organ market debate.21112000Aronsohn A, Jensen DClinics in liver diseaseHepatobiliary manifestations of critically ill and postoperative patients. Clin Liver Dis. 2011 Feb; 15(1):183-97.Clin Liver Dis2011-02-01T00:00:002011Hepatobiliary manifestations of critically ill and postoperative patients.22807004Aronsohn A, Jensen DHepatology (Baltimore, Md.)Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse. Hepatology. 2012 Nov; 56(5):1591-2.Hepatology2012-11-01T00:00:002012Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse.Authorship 147233934124343Cotter TG, Wang J, Lieber SR, Odenwald MA, Rich NE, Marrero JA, Singal AG, Mitchell MC, Aronsohn A, Charlton M, Fung JTransplantation direct"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era. Transplant Direct. 2021 Jul; 7(7):e707.Transplant Direct2021-06-08T00:00:002021"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era.Authorship 147614234156077Tilmon S, Aronsohn A, Boodram B, Canary L, Goel S, Hamlish T, Kemble S, Lauderdale DS, Layden J, Lee K, Millman AJ, Nelson N, Ritger K, Rodriguez I, Shurupova N, Wolf J, Johnson DJournal of public health (Oxford, England)HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago. J Public Health (Oxf). 2022 12 01; 44(4):891-899.J Public Health (Oxf)2022-12-01T00:00:002022HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago.21520197Aronsohn A, Jensen DHepatology (Baltimore, Md.)Distributive justice and the arrival of direct-acting antivirals: who should be first in line? Hepatology. 2011 Jun; 53(6):1789-91.Hepatology2011-06-01T00:00:002011Distributive justice and the arrival of direct-acting antivirals: who should be first in line?19731030Rubin DT, Gandhi RK, Hetzel JT, Kinnear SH, Aronsohn A, Wood G, Yadron NDigestive diseases and sciencesDo colorectal cancer patients understand that their family is at risk? Dig Dis Sci. 2009 Nov; 54(11):2473-83.Dig Dis Sci2009-11-01T00:00:002009Do colorectal cancer patients understand that their family is at risk?22855699Yang L, Aronsohn A, Hart J, Jensen DWorld journal of hepatologyHerbal hepatoxicity from Chinese skullcap: A case report. World J Hepatol. 2012 Jul 27; 4(7):231-3.World J Hepatol2012-07-27T00:00:002012Herbal hepatoxicity from Chinese skullcap: A case report.D016174Living Beings431590.893796HepacivirusD019698Disorders331260.882115Hepatitis C, Chronichttp://www.researchgate.net/profile/John_Fung2/stats/Research Gatehttp://biomedsciences.uchicago.edu/page/glenn-randall-phdRandall lab websitehttps://publons.com/author/1183306/john-fung#profilePublonshttps://www.healthtap.com/#experts/11185863/aboutHealth Taphttps://orcid.org/0000-0002-3038-0441ORCIDChristopherLehmannChristopher Lehmann41.7886000000000087.598699999999994319Lehmann, Christopher0000-0002-1111-2169Assistant ProfessorAuthorship 1648561Authorship 164888136515956Aronsohn AJAMA network openIdentifying Stigma as a Key Initial Step to Equitable Hepatitis C Virus Care. JAMA Netw Open. 2022 Dec 01; 5(12):e2246610.JAMA Netw Open2022-12-01T00:00:002022Identifying Stigma as a Key Initial Step to Equitable Hepatitis C Virus Care.34859470Aronsohn AI, Bhattacharya D, Morgan TR, Wyles DL, Chung RT, McQuillen DP, AASLD-IDSA HCV GuidanceHepatology (Baltimore, Md.)Reply. Hepatology. 2022 04; 75(4):1055-1056.Hepatology2021-12-19T00:00:002021Reply.https://dfi.uchicago.edu/Duchossois Family InstituteSurgeryUniversity of ChicagoRichardWhitleyRichard Whitley41.78927490000000-87.601250000000001238Whitley, RichardEugene B.Chang0mBqA6AbHszMknJtY0fp/Cv/+94=Eugene B. Chang41.78927490000000-87.601250000000001255Chang, Eugene B.Professor4.440490.0120204150research areas0.5606370.027836625coauthor of133.0465.5607260similar to1140selected publicationsBruceBissonnette1Wt6WIF1GuTQkntjbwjr93A=Bruce Bissonnette41.78927490000000-87.601250000000001417Bissonnette, BruceAssociate ProfessorGlenn C.Randall0HBoBaUUFeD5hHlsaUXv9Gq0+s+oGlenn C. Randall41.78927490000000-87.601250000000001767Randall, Glenn C.ProfessorKarenKimKaren Kim41.78927490000000-87.601250000000001769Kim, KarenProfessorKapuluruReddyKapuluru Reddy41.78927490000000-87.60125000000000189Reddy, KapuluruAssociate ProfessorAuthorship 1672493237845315Odenwald MA, Lin H, Lehmann C, Dylla NP, Cole CG, Mostad JD, Pappas TE, Ramaswamy R, Moran A, Hutchison AL, Stutz MR, Dela Cruz M, Adler E, Boissiere J, Khalid M, Cantoral J, Haro F, Oliveira RA, Waligurski E, Cotter TG, Light SH, Beavis KG, Sundararajan A, Sidebottom AM, Reddy KG, Paul S, Pillai A, Te HS, Rinella ME, Charlton MR, Pamer EG, Aronsohn AINature microbiologyBifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.Nat Microbiol2023-10-16T00:00:002023Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease.Russell D.CohenRussell D. Cohen41.78927490000000-87.601250000000002354Cohen, Russell D.ProfessorHelen S.TeHelen S. Te41.78927490000000-87.601250000000002428Te, Helen S.ProfessorAuthorship 1688341838103544Lehmann CJ, Dylla NP, Odenwald M, Nayak R, Khalid M, Boissiere J, Cantoral J, Adler E, Stutz MR, Dela Cruz M, Moran A, Lin H, Ramaswamy R, Sundararajan A, Sidebottom AM, Little J, Pamer EG, Aronsohn A, Fung J, Baker TB, Kacha ACell host & microbeFecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.Cell Host Microbe2023-12-15T00:00:002023Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection.true1true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 651701Authorship 732101Authorship 775961Authorship 68370123788009Aronsohn A, Jensen DHepatology (Baltimore, Md.)Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy. Hepatology. 2014 Jan; 59(1):13-5.Hepatology2013-10-22T00:00:002013Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy.24131506Aronsohn A, Ancuta I, Caruntu F, Coppola C, Delic D, Digiacomo A, Dusheiko GM, Lengyel G, Marcellin P, Orlandini A, Pruthi J, Silva GF, Tallarico L, Schmitz M, Tatsch F, Korner E, Cheinquer HJournal of viral hepatitisImpact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort. J Viral Hepat. 2014 May; 21(5):377-80.J Viral Hepat2013-10-17T00:00:002013Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort.24806752Aronsohn A, Reau N, Jensen DHepatology (Baltimore, Md.)Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus. Hepatology. 2014 May; 59(5):1688-91.Hepatology2014-03-01T00:00:002014Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus.24782256Aronsohn A, Jensen DSeminars in liver diseaseInterferon-combination strategies for the treatment of chronic hepatitis C. Semin Liver Dis. 2014 Feb; 34(1):30-6.Semin Liver Dis2014-04-29T00:00:002014Interferon-combination strategies for the treatment of chronic hepatitis C.1010Chicago60637ILAuthorship 80569326157902Fritz CD, Adebajo C, Aronsohn A, Jensen DMACG case reports journalA New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy. ACG Case Rep J. 2014 Oct; 2(1):42-4.ACG Case Rep J2014-10-10T00:00:002014A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy.Authorship 80758225363161Mikolajczyk AE, Aronsohn AA, McConville JF, Jensen DM, Farnan JMHepatology (Baltimore, Md.)A call to action: The need for hepatology-focused educational interventions in Internal Medicine Residency training. Hepatology. 2015 Aug; 62(2):655-6.Hepatology2015-06-12T00:00:002015A call to action: The need for hepatology-focused educational interventions in Internal Medicine Residency training.Authorship 81487226311596Mikolajczyk AE, Aronsohn AIAdvances in chronic kidney diseaseCurrent Management of Chronic Hepatitis B and C in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2015 Sep; 22(5):352-60.Adv Chronic Kidney Dis2015-09-01T00:00:002015Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease.Authorship 82760325742912Sengupta S, Wroblewski K, Aronsohn A, Reau N, Reddy KG, Jensen D, Te HDigestive diseases and sciencesScreening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start? Dig Dis Sci. 2015 Oct; 60(10):3130-5.Dig Dis Sci2015-03-06T00:00:002015Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?Authorship 85022526658760Berg MG, Lee D, Coller K, Frankel M, Aronsohn A, Cheng K, Forberg K, Marcinkus M, Naccache SN, Dawson G, Brennan C, Jensen DM, Hackett J, Chiu CYPLoS pathogensDiscovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection. PLoS Pathog. 2015 Dec; 11(12):e1005325.PLoS Pathog2015-12-11T00:00:002015Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection.Authorship 89224326642977Gaetano JN, Micic D, Aronsohn A, Reddy G, Te H, Reau NS, Jensen DJournal of gastroenterology and hepatologyThe benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.J Gastroenterol Hepatol2016-05-01T00:00:002016The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.SonaliPaulSonali Paul0.000000000000000.000000000000003376Paul, SonaliAssistant ProfessorJohnFungJohn Fung0.000000000000000.000000000000003383Fung, JohnProfessorAuthorship 613271AnjanaPillaiAnjana Pillai0.000000000000000.000000000000003399Pillai, AnjanaAssociate Professor23352458Aronsohn A, Muir AJ, Swan T, Jensen DGastroenterologyIs the HCV pipeline heading in the right direction? Gastroenterology. 2013 Mar; 144(3):482-5.Gastroenterology2013-01-23T00:00:002013Is the HCV pipeline heading in the right direction?Authorship 95963827506929Mikolajczyk AE, Farnan JM, McConville JF, Jensen DM, Reddy KG, Te HS, Reau N, Aronsohn AIHepatology (Baltimore, Md.)Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatology. Hepatology. 2016 12; 64(6):2210-2218.Hepatology2016-10-01T00:00:002016Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatology.Authorship 99602228160311Carter LDB, Aronsohn AHepatology (Baltimore, Md.)Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients. Hepatology. 2017 05; 65(5):1735-1740.Hepatology2017-03-31T00:00:002017Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients.